Return to Organic Revenue Growth
In Q4, EPAM reported a mid-single-digit growth year-over-year and sequentially, returning to organic revenue growth for the first time since Q1 of 2023. This was driven by improvements in client sentiments and engagements across all verticals and geographies, especially in AI-related capabilities.
Successful Acquisitions and Expansion
The acquisitions of NEORIS and First Derivative significantly expanded EPAM's global footprint, adding nearly 6,000 employees across Latin America, Canada, Spain, UK, and Ireland. These acquisitions are expected to accelerate EPAM's strategy and improve its market position.
Strong Performance in Key Verticals
Four out of six verticals grew year-over-year, with strong momentum in life sciences, healthcare, software and high tech, and financial services. The Americas and APAC regions led the growth year-over-year.
Growth in AI Engagements
EPAM reported significant traction in GenAI initiatives, with 75% of top country clients engaged. The revenue from AI-native programs reached about $50 million in Q4, reflecting strong growth in early-stage projects.
Record Headcount Growth
EPAM ended Q4 with over 61,200 employees, including significant contributions from recent acquisitions and organic growth. Notably, India became the largest single country delivery location for EPAM, now representing over 10,000 employees.